Beirne Wealth Consulting Services, LLC

Position in NVAX — Novavax Inc

CIK 1697303 SHELTON, CT

Position in NVAX

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$122,100

+$21,300 QoQ

Shares Held

15,000

0.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Beirne Wealth Consulting Services, LLC holds $1,461,722 across 3 Biotechnology names. NVAX ranks #2 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALT	Altimmune, Inc.	411,858	$1,268,522
2	NVAX	Novavax Inc This page	15,000	$122,100
3	LCTX	Lineage Cell Therapeutics, Inc.	45,000	$71,100

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$122,100	15,000	0.0%	Shares	Sole	2026-04-30
2025-12-31	$100,800	15,000	0.0%	Shares	Sole	2026-01-29
2025-09-30	$130,050	15,000	+50.0%	Shares	Sole	2025-11-07
2025-06-30	$63,000	10,000	0.0%	Shares	Sole	2025-08-04
2025-03-31	$64,100	10,000	-39.4%	Shares	Sole	2025-05-01
2024-12-31	$132,660	16,500	+65.0%	Shares	Sole	2025-01-31
2024-09-30	$126,300	10,000	+217.5%	Shares	Sole	2024-11-07
2022-03-31	$231,997	3,150	+162.5%	Shares	Sole	2022-05-10
2021-09-30	$248,772	1,200	-36.8%	Shares	Sole	2021-11-09
2021-06-30	$403,389	1,900	+58.3%	Shares	Sole	2021-08-10
2021-03-31	$217,572	1,200	-94.6%	Shares	Sole	2021-05-17
2020-06-30	$1,854,537	22,250	-62.9%	Shares	Sole	2020-07-31
2020-03-31	$814,800	60,000	—	Shares	Sole	2020-04-28
No filing history on record for this holder in this stock.